CN
79-29-8
应用筛选条件
关键词:'79-29-8'
显示 31-60 共 252 条结果 关于 "79-29-8" 范围 技术文档
Data Sheet - SAB4200111
Christensen, H.S., et al., J. Virol., 81, 5121-5131
(2007).
4. Ong, C.L., et al., J. Virol., 79, 12763-12772
(2005).
5. Zhong, J., et al., Nat. Genet., 22, 171-174
(1999).
6. Bannwarth
Product Information Sheet - H5882
A., and Simons, K., Solubilization of
Membranes by Detergents. Biochim. Biophys.
Acta., 415(1), 29-79 (1975).
5. Biochemika 1989 Handbook, p. 557.
6. Data for Biochemical Research, 3rd ed., Dawson
Fast GC-A Practical Guide for Increasing Sample Throughput without Sacrificing Quality
76,7778
79
80
81
82
83 84,85
86
3.0 4.0 5.0 6.0 7.02.0 Min
1
2 3
4
5
6
7
8
9
10
11
12
13
14
15
16
Data Sheet - P9599
in ornamental
tobacco floral nectary development". Iowa State
University, Ph.D. dissertation, p. 79 (2007).
16. Teotia, Sachin, "Characterization of two
paralogous genes RADICAL-INDUCED CELL
GOAT ANTI-CHOLINE ACETYLTRANSFERASE (ChAT) AFFINITY PURIFIED POLYCLONAL ANTIBODY
Brain Research (1990) 532:317-322.
6. J. Neuroscience Methods (1990) 35:31-37.
7. Cell (1994) 79:729-742.
8. J. Neurochemistry (1995) 65:484-491.
9. Neuroscience (1995) 67:679-688.
10. J. Comparative
Product Information Sheet - P6887
Macronutrients Digestion and
Fermentation Kinetics". University of Queensland,
M.Sc. thesis, pp. 36, 79 (2018).
17. Huang, Xiaojing, "Characterizing the
Structure-Function Relationship of Pathological
Data Sheet - C7479
al., J Cell Biol., 105, 1845 (1987).
2. Parmentier, M., and Lafort, A., Eur. J. Biochem.,
196, 79 (1991).
3. Heizmann, C.W., Gen. Physiol. Biophys., 11, 411
(1992).
4. Baimbridge, K.G., et al
Bioactive Lipids Technical Bulletin
269, 3181.
29. Gomez-Munoz, A., et al. 1995. Mol. Pharmacol. 47,
833.
30. Berger, A., et al. 1995. Proc. Natl. Acad. Sci. USA 92,
5885.
31. Dettbarn, C., et al. 1995. Brain Res. 669, 79.
Product Information Sheet - B9808
specifically with B42-fusion
proteins. Specific staining is inhibited by the B42
immunizing peptide.
The 79 amino acid peptide B42 is one of several short
peptides encoded by E. coli genomic DNA fragments
Rotary Evaporator Replacement Glassware
1100 79
Tel: (+27) 11 979 1188
Fax: (+27) 11 979 1119
Spain
Free Tel: 900 101 376
Free Fax: 900 102 028
Tel: (+34) 91 661 99 77
Fax: (+34) 91 661 96 42
Sweden
Tel: (+46) 8 742 4200
Fax: (+46) 8 742
MOUSE ANTI-CHOLINE ACETYLTRANSFERASE (ChAT) MONOCLONAL ANTIBODY
2. PNAS USA (1982) 79:7031-7035.
3. PNAS USA (1986) 83:5316-5320.
4. Brain Res. (1987) 402:30-43.
5. Exp. Neurology (1988) 101:303-312.
6. Brain Research (1989) 505:29-38.
7. Exp. Neurology
Datasheet - A8592
and Oncogenesis”. University of
Nebraska Medical Center, Ph.D. dissertation,
pp. 29, 66, 123 (December 2016).
29. Kanai, Stanley Michinobu, “Mechanisms of G
Protein Regulation by RGS Proteins and
Data Sheet - CLLS1051
calmodulin-dependent protein kinase III
(elongation factor 2-kinase) in human breast
cancer. Br. J. Cancer., 79 (1), 59-64 (1999).
2. Arora, S. et al., Identification and characterization
of an inhibitor of
Product Information Sheet - CLLS1053
Journal of Clinical Oncology:
official journal of the American Society of Clinical
Oncology, 28, 3366-79 (2010).
4. O’Regan, R., and Hawk, N.N., mTOR inhibition in
breast cancer: unraveling the complex
DataSheet - D5025
The Role of
NDFIP1 in T Cell Tolerance". University of
Pennsylvania, Ph.D. dissertation, pp. 37, 79
(2013).
The life science business of Merck operates
as
FcFusionProteinSeparation
min0 2 4 6 8 10 12 14 16 18
mAU
0
10
20
30
40
50
60
70
80
6.
14
0 6.
79
4
7.
47
8
Product Information Sheet - N2770
NJ), Vol. 29, pp. 451-472 (2000).
6. Dean, G.S., and Isenberg, D.A., Clin. Exp.
Rheumatol., 19(3), 251-257 (2001).
7. Permar, S.R. et al., J. Virol., 77(7), 4396-4400
(2003).
8. Arnold, J.N
LABORATORY NOTEBOOK ISSUANCE PAGE
3
74
.9
22
78
.9
6
79
.9
04
83
.7
98
11
4.
82
11
8.
71
12
1.
76
12
7.
60
12
6.
90
13
1.
29
20
4.
38
20
7.
2
20
8.
Lab Notebook Guidelines
3
74
.9
22
78
.9
6
79
.9
04
83
.7
98
11
4.
82
11
8.
71
12
1.
76
12
7.
60
12
6.
90
13
1.
29
20
4.
38
20
7.
2
20
8.
Product Information Sheet - DN25
for in vitro Models of Respiratory
Epithelium". University of Toronto, Ph.D.
dissertation, p. 79 (2018).
20. Hähle, Andreas, "Elucidation of the molecular and
cellular mechanisms of FKBP51-selective
LABORATORY NOTEBOOK ISSUANCE PAGE
3
74
.9
22
78
.9
6
79
.9
04
83
.7
98
11
4.
82
11
8.
71
12
1.
76
12
7.
60
12
6.
90
13
1.
29
20
4.
38
20
7.
2
20
8.
LABORATORY NOTEBOOK ISSUANCE PAGE
3
74
.9
22
78
.9
6
79
.9
04
83
.7
98
11
4.
82
11
8.
71
12
1.
76
12
7.
60
12
6.
90
13
1.
29
20
4.
38
20
7.
2
20
8.
Product Information Sheet - D0627
3rd edition. Clarendon Press
(Oxford, UK), pp. 78-79 (1986).
28. Wilding, T.J. et al., J. Neurosci., 15(5),
4124-4132 (1995).
29. Major, T. et al., Curr. Protoc. Stem Cell Biol., 39
Product Information Sheet - D0260
al., Data for Biochemical
Research, 3rd edition. Clarendon Press
(Oxford, UK), pp. 78-79 (1986).
29. Wilding, T.J. et al., J. Neurosci., 15(5),
4124-4132 (1995).
30. Major, T. et al.
Anti-NeuN, clone A60 - Data Sheet
., J. Neuroscience (2005) 25:10729-10729.
78) Mukouyama, Y., et al., PNAS (2006) 103:1551-1556.
79) Bick-Sander, A., et al., PNAS (2006) 103:3852-3857.
80) Zhao, B., et al., Nature Medicine (2006)
Validation of Milliflex Quantum for bioburden testing of pharmaceutical products - PDA Journal of Pharmaceutical Science and Technology 2017 71 206-224 (Oliver Gordon et al)
33 � 6 0.92 0.92
Staphylococcus warneri 9/9 38 � 8 37 � 8 0.80 0.87
Pseudomonas stutzeri 6/6 48 � 7 41 � 8 0.13 0.95
Kocuria rhizophila 6/6 79 � 7 77 � 9 0.64
Product Information Sheet - R2625
Page 1 of 3
10/08/96 - ARO
all trans-RETINOIC ACID
Sigma Prod. No. R 2625
CAS NUMBER: 302-79-4
SYNONYMS: Vitamin A Acid; Retinoic Acid; Tretinoin1; all-trans-
Vitamin A1 Acid; all-(E)-Retinoic
Product Information sheet - N2770
Mol. Med., 29,
451-472 (2000).
6. Dean, G.S., and Isenberg, D.A., Clin. Exp.
Rheumatol., 19(3), 251-257 (2001).
7. Permar, S.R. et al., J. Virol., 77(7), 4396-4400
(2003).
8. Arnold
Verfication summary-03-0202-00
83.78 8.1 10% 102%
3 1:16 4.36 1.2 29% 69.83 20.0 29% 85%
2 1:32 2.82 0.6 21% 90.30 19.4 21% 110%
HMN686707
3 MRD (1:4) 26.71 1.5 6% 106.83 5.9 6% -
3 1:8 13.33
Verfication summary-03-0202-00
83.78 8.1 10% 102%
3 1:16 4.36 1.2 29% 69.83 20.0 29% 85%
2 1:32 2.82 0.6 21% 90.30 19.4 21% 110%
HMN686707
3 MRD (1:4) 26.71 1.5 6% 106.83 5.9 6% -
3 1:8 13.33
2/9